- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Polyethylene glycol-modified human recombinant truncated cys
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase
| EU orphan designation number: | EU/3/16/1664
|
| Active ingredient: | Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase |
| Indication: | Treatment of homocystinuria |
| Sponsor: | Alan Boyd Consultants Ltd
Electra House, Crewe Business Park, Crewe, Cheshire CW1 6GL, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/06/2016 | Orphan designation | EMA/OD/025/16 | (2016)3419 of 30/05/2016 |
CONTACT
EU links
Directorate General Health & Consumers